{
    "Trade/Device Name(s)": [
        "On Call\u00ae Home Drug Test for Marijuana",
        "On Call\u00ae Home Drug Test for Marijuana and Cocaine"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K050936",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040327",
        "K003557",
        "K020313"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "DIO"
    ],
    "Summary Letter Date": "June 24, 2005",
    "Summary Letter Received Date": "April 14, 2005",
    "Submission Date": "April 13, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3870",
        "21 CFR 862.3250"
    ],
    "Regulation Name(s)": [
        "Marijuana, or Marijuana and Cocaine test system",
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana (THC)",
        "Cocaine (COC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatography"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for On Call Home Drug Test for Marijuana and On Call Home Drug Test for Marijuana & Cocaine, rapid lateral flow immunoassays for qualitative detection of drugs of abuse in urine.",
    "Indications for Use Summary": "Over-the-counter rapid screening tests for preliminary detection of Marijuana (THC) and Cocaine (COC) and their metabolites in urine; intended as the first step in a two-step process with laboratory confirmation for positive results.",
    "fda_folder": "Toxicology"
}